Short interest in CytoMed Therapeutics Ltd (NASDAQ:GDTC) decreased during the last reporting period, falling from 76.80K to 75.56K. This put 4.43% of the company's publicly available shares short.

Short interest for CytoMed Therapeutics gives investors a sense of the degree to which investors are betting on the decline of CytoMed Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 7.06K shares traded per day, it would take 10.7 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.